These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17143512)

  • 1. Gene expression profile as a prognostic factor in high-grade gliomas.
    Czernicki T; Zegarska J; Paczek L; Cukrowska B; Grajkowska W; Zajaczkowska A; Brudzewski K; Ulaczyk J; Marchel A
    Int J Oncol; 2007 Jan; 30(1):55-64. PubMed ID: 17143512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of gliomas strongly predicts survival.
    Freije WA; Castro-Vargas FE; Fang Z; Horvath S; Cloughesy T; Liau LM; Mischel PS; Nelson SF
    Cancer Res; 2004 Sep; 64(18):6503-10. PubMed ID: 15374961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
    Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
    Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma.
    Shinohara C; Muragaki Y; Maruyama T; Shimizu S; Tanaka M; Kubota Y; Oikawa M; Nakamura R; Iseki H; Kubo O; Takakura K; Hori T
    Jpn J Clin Oncol; 2008 Nov; 38(11):730-3. PubMed ID: 18820008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression pattern and clinical prognostic relevance of bone morphogenetic protein-2 in human gliomas.
    Liu C; Tian G; Tu Y; Fu J; Lan C; Wu N
    Jpn J Clin Oncol; 2009 Oct; 39(10):625-31. PubMed ID: 19797419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of expressed genes characterizing long-term survival in malignant glioma patients.
    Yamanaka R; Arao T; Yajima N; Tsuchiya N; Homma J; Tanaka R; Sano M; Oide A; Sekijima M; Nishio K
    Oncogene; 2006 Sep; 25(44):5994-6002. PubMed ID: 16652150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood.
    Bredel M; Pollack IF; Hamilton RL; James CD
    Clin Cancer Res; 1999 Jul; 5(7):1786-92. PubMed ID: 10430083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
    Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
    Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
    Gravendeel LA; Kouwenhoven MC; Gevaert O; de Rooi JJ; Stubbs AP; Duijm JE; Daemen A; Bleeker FE; Bralten LB; Kloosterhof NK; De Moor B; Eilers PH; van der Spek PJ; Kros JM; Sillevis Smitt PA; van den Bent MJ; French PJ
    Cancer Res; 2009 Dec; 69(23):9065-72. PubMed ID: 19920198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas.
    Bredel M; Pollack IF; Campbell JW; Hamilton RL
    Clin Cancer Res; 1997 Nov; 3(11):2157-64. PubMed ID: 9815610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas.
    Varela M; Ranuncolo SM; Morand A; Lastiri J; De Kier Joffé EB; Puricelli LI; Pallotta MG
    J Surg Oncol; 2004 Apr; 86(1):34-40. PubMed ID: 15048678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
    Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
    Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
    Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
    Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.
    Fuller GN; Mircean C; Tabus I; Taylor E; Sawaya R; Bruner JM; Shmulevich I; Zhang W
    Oncol Rep; 2005 Sep; 14(3):651-6. PubMed ID: 16077969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis.
    Shirahata M; Iwao-Koizumi K; Saito S; Ueno N; Oda M; Hashimoto N; Takahashi JA; Kato K
    Clin Cancer Res; 2007 Dec; 13(24):7341-56. PubMed ID: 18094416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas.
    Galanis E; Buckner J; Kimmel D; Jenkins R; Alderete B; O'Fallon J; Wang CH; Scheithauer BW; James CD
    Int J Oncol; 1998 Oct; 13(4):717-24. PubMed ID: 9735401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J; Deng Y; Yang G; Xie W
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 4-gene signature associated with clinical outcome in high-grade gliomas.
    de Tayrac M; Aubry M; Saïkali S; Etcheverry A; Surbled C; Guénot F; Galibert MD; Hamlat A; Lesimple T; Quillien V; Menei P; Mosser J
    Clin Cancer Res; 2011 Jan; 17(2):317-27. PubMed ID: 21224364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters assessing neurological status in malignant glioma patients: prognostic value for survival and relapse-free time.
    Martinez R; Volter C; Behr R
    Br J Neurosurg; 2008 Aug; 22(4):557-62. PubMed ID: 18686059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.